PT Hetzer Medical Indonesia Tb

MEDS · JK · Healthcare / Medical Instruments & Supplies

64.00IDR+4.00 (+6.67%)

Price History

Full chart

Market Stats

Previous Close60.00

Open60.00

Day Range60.00 – 65.00

52-Week Range53.00 – 157.00

Volume21.61M

Market Cap115.63B

P/E (TTM)0.00

Forward P/E0.00

Dividend Yield0.00%

Beta1.18

50-Day Avg76.88

200-Day Avg76.43

About

PT Hetzer Medical Indonesia Tbk manufactures and sells 4D masks in Indonesia. It offers stethoscopes, bouffant caps, face masks, and tensiometer. The company was founded in 2010 and is based in Cimahi, Indonesia.

Company Details

SectorHealthcare
IndustryMedical Instruments & Supplies
CEODr. Yenny Marlina
Employees18
HeadquartersBlue Sky Industrial Complex (BSI) Plot No. 09, Cimahi, Indonesia, 40532, Indonesia
Websitehttps://www.evoplusmed.com

Leadership

Dr. Yenny MarlinaPresident Director & Corporate Secretary · b. 1984
Ms. Fancy MarsianaDirector of Finance & Director · b. 1969
Mr. - HerryDirector of Operations & Director
Dera Susanty HermanHead of Internal Audit

Financials

Income Statement

Currency: IDR	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	12.02B	87.79B	75.79B	37.74B	22.72B	6.39B	6.63B
Growth (%)	-	+630.26%	-13.67%	-50.21%	-39.79%	-71.87%	+3.73%
Cost of Revenue	8.99B	28.62B	22.19B	19.20B	14.33B	7.78B	8.03B
Gross Profit	3.03B	59.17B	53.60B	18.53B	8.39B	-1.39B	-1.40B
Gross Margin	25.19%	67.40%	70.72%	49.11%	36.92%	-21.78%	-21.13%
Operating Expense	2.61B	10.52B	19.51B	13.95B	10.89B	7.18B	6.84B
Operating Income	421.36M	48.65B	34.09B	4.59B	-2.50B	-8.57B	-8.24B
Operating Margin	3.51%	55.41%	44.98%	12.16%	-11.02%	-134.17%	-124.33%
EBITDA	626.62M	49.46B	36.04B	7.52B	1.55B	-3.30B	-4.00B
EBITDA Margin	5.21%	56.34%	47.55%	19.93%	6.82%	-51.61%	-60.36%
Net Income	308.42M	37.96B	26.63B	237.06M	-3.57B	-8.53B	-8.35B
Net Income Margin	2.57%	43.24%	35.14%	0.63%	-15.71%	-133.52%	-125.90%
R&D	55.50M	728.18M	-	-	-	-	-
R&D as % of Total Revenue	0.46%	0.83%	-	-	-	-	-
Interest Expense	1.30M	10.10M	180.42M	759.20M	663.42M	482.40M	672.71M
Interest Expense % of Total Revenue	0.01%	0.01%	0.24%	2.01%	2.92%	7.55%	10.15%

Balance Sheet

Currency: IDR	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	7.74B	30.89B	49.98B	80.93B	77.13B	65.31B	61.77B
Total Liabilities	3.51B	17.86B	17.52B	12.14B	11.97B	8.69B	13.47B
Total Equity	4.23B	13.03B	32.46B	68.79B	65.16B	56.62B	48.30B
Cash	540.09M	13.87B	1.40B	5.36B	665.57M	232.09M	779.02M
Total Debt	-	2.22B	11.29B	10.03B	7.97B	5.19B	8.00B
Net Debt	-540.09M	-11.65B	9.89B	4.67B	7.31B	4.96B	7.22B

Cash Flow

Currency: IDR	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	-2.61B	48.68B	13.48B	-13.02B	3.15B	2.23B	-1.48B
Investing Cash Flow	-863.71M	-7.38B	-27.72B	-17.73B	-6.09B	361.09M	-1.11B
Financing Cash Flow	3.82B	-27.97B	1.77B	34.71B	-1.76B	-3.02B	3.13B
Capital Expenditure	863.71M	7.38B	27.01B	17.97B	6.09B	275.84M	1.26B
Free Cash Flow	-3.47B	41.31B	-13.52B	-30.99B	-2.94B	1.95B	-2.73B
Dividends Paid	-	29.00B	7.20B	0	-	-	-
FCF to OCF	133.11%	84.85%	-100.30%	237.99%	-93.13%	87.63%	185.15%
Dividend Paid to FCF	-	70.21%	-53.24%	0.00%	-	-	-

Earnings

Report Date	Dec 31, 2022	Mar 31, 2023	Jun 30, 2023
EPS Estimate	-	-	-
EPS Actual	-1.73	-3.07	-2.41
Surprise	-	-	-
Timing	-	-	-

Key Statistics & Ratios

Market Cap115.63B

Enterprise Value126.56B

Trailing P/E0.00

Forward P/E0.00

Price / Sales7.70

Price / Book0.00

Book Value31.12

Revenue (TTM)15.01B

Gross Profit (TTM)4.73B

EBITDA-128.86M

Profit Margin-27.68%

Operating Margin12.93%

Return on Equity-8.20%

Return on Assets-3.89%

Shares Outstanding1.56B

Shares Float739.98M

Beta1.18

Dividend Yield0.00%

Dividend Rate0.00

Payout Ratio0.00%